Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is widely used as an anaesthetic for general anesthesia during surgery.
Previous studies in cells and animals show that dexmedetomidine may promote cancer growth.
The purpose of present study is to examine whether utilization of dexmedetomidine in patients
undergoing surgery for primary breast cancer increases breast cancer recurrence and
metastasis, and to investigate its effects on the patients' immune system.
Phase:
N/A
Details
Lead Sponsor:
RenJi Hospital
Collaborators:
Shanghai 10th People's Hospital Shanghai Pudong Hospital Shanghai Seventh People's Hospital Shanghai Tongji Hospital, Tongji University School of Medicine